Henry Schein, Inc. HSIC
Nov 3, 2026, 3:42 PM EST
- YTD
- +8.69%
- 1 year
- +27.08%
- Market cap
- 9.16B
- Revenue (ttm)
- 13.60B
- Profit margin
- 2.96%
- EPS (ttm)
- 3.43
- Shares out
- 111.45M
- P/E ratio
- 23.96
- Forward P/E
- 14.46
- YTD return
- +8.69%
- 1-year return
- +27.08%
- Volume
- 3.05M
- Avg volume
- 1.17M
- Open
- 82.37
- Previous close
- 86.62
- Day's range
- 81.05 – 86.87
- 52-week range
- 64.64 – 90.86
- Beta
- 0.86
- Analysts
- Buy
- Price target
- 96.87 (+17.9%)
- Earnings date
- Nov 3, 2026
6M +10.48 (+14.55%)
Key statistics
- Enterprise value
- 14.68B
- PEG ratio
- 1.69
- Price / sales
- 0.71
- Price / book
- 3.07
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 6.70%
- Free cash flow
- 446.00M
- Total cash
- 157.00M
- Total debt
- 3.81B
- Return on equity
- 8.85%
- Short % of float
- 9.79%
- 50-day average
- 86.53
- 200-day average
- 81.06
Analyst view
Consensus: buy
- Target (low)
- 64.00
- Target (mean)
- 96.87
- Target (high)
- 110.00
- Strong buy4
- Buy4
- Hold7
- Sell1
- Strong sell0
Next earnings
Nov 3, 2026
Expected Nov 3, 2026. Consensus EPS estimate 1.36.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 3, 2026 | Sep 27, 2026 | 1.36 | — | — | — |
| Aug 4, 2026 | Jun 27, 2026 | 1.24 | 1.27 | +0.03 | +2.42% |
| May 5, 2026 | Mar 28, 2026 | 1.20 | 1.32 | +0.12 | +10.00% |
| Feb 24, 2026 | Dec 27, 2025 | 1.30 | 1.34 | +0.04 | +3.08% |
| Nov 4, 2025 | Sep 27, 2025 | 1.27 | 1.38 | +0.11 | +8.66% |
| Aug 5, 2025 | Jun 28, 2025 | 1.18 | 1.10 | -0.08 | -6.78% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 14, 2026 | Leerink Partners | main | Market Perform | Market Perform |
| Aug 19, 2026 | BTIG | main | Buy | Buy |
| Aug 6, 2026 | Barclays | main | Overweight | Overweight |
| Aug 5, 2026 | UBS | main | Neutral | Neutral |
| Aug 5, 2026 | Citigroup | main | Buy | Buy |
| Aug 5, 2026 | BTIG | reit | Buy | Buy |
About Henry Schein, Inc.
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Country
- United States
- Website
- henryschein.com
News
What Henry Schein (HSIC) Said on Its Q3 Earnings Call
Henry Schein Sees Pressure From Discretionary Dental Delays
Compared to Estimates, Henry Schein (HSIC) Q3 Earnings: A Look at Key Metrics
HSIC Q3 Earnings Beat, Revenues Match, '26 EPS View Up, Stock Down
Henry Schein Q3 2026 Earnings Call Transcript
Henry Schein (HSIC) Tops Q3 Earnings Estimates Henry Schein Raises FY2026 Adj EPS Guidance from $5.29-$5.39 to $5.50-$5.56 vs $5.39 Est; Affirms FY2026 Sales Guidance of $13.794B-$13.926B vs $13.866B Est
Henry Schein Q3 Adj. EPS $1.56 Beats $1.36 Estimate, Sales $3.471B Miss $3.476B Estimate
Henry Schein Reports Strong 2026 Third Quarter and Raises FY2026 Guidance
Why Henry Schein (HSIC) is a Top Momentum Stock for the Long-Term
Your note
Sign in to keep a note on HSIC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ALBERTINI ANDREA | Officer | Stock Award(Grant) | Mar 5, 2026 | 122,092 |
| BERGMAN STANLEY M | Director | Stock Gift | May 25, 2026 | 643,124 |
| BRESLAWSKI JAMES P | President | Stock Award(Grant) | Mar 9, 2025 | 206,542 |
| CONNETT BRADFORD C | Officer | Sale | Mar 18, 2025 | 62,688 |
| ETTINGER MICHAEL S. | Chief Operating Officer | Stock Gift | Mar 16, 2026 | 112,418 |
| LOWERY FREDERICK M. | Chief Executive Officer | Stock Award(Grant) | Mar 5, 2026 | 95,156 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Kohlberg Kravis Roberts & Co. L.P. | 14.04% | 15,652,032 | 1.36B | Jun 29, 2026 |
| FMR, LLC | 6.78% | 7,553,901 | 654.32M | Jun 29, 2026 |
| Blackrock Inc. | 6.30% | 7,024,663 | 608.48M | Jun 29, 2026 |
| Artisan Partners Limited Partnership | 5.80% | 6,467,467 | 560.21M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 5.69% | 6,346,669 | 549.75M | Jun 29, 2026 |
| JPMORGAN CHASE & CO | 3.90% | 4,342,929 | 376.18M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.77% | 3,088,611 | 267.54M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.25% | 2,507,310 | 217.18M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.00% | 2,231,443 | 193.29M | Jun 29, 2026 |
| Invesco Exchange-Traded Fund Trust-Invesco S&P 500 Equal Weight ETF | 2.00% | 2,223,555 | 192.60M | Sep 29, 2026 |
| Fidelity Puritan Trust-Fidelity Low-Priced Stock Fund | 1.94% | 2,164,774 | 187.51M | Jul 30, 2026 |
| J.P. Morgan Fleming Mutual Fd. Group, Inc.-JPMorgan Mid Cap Value Fd. | 1.44% | 1,606,529 | 139.16M | Jun 29, 2026 |
